Celcuity, Inc. (CELC)
105.79
+0.64
(+0.61%)
USD |
NASDAQ |
Feb 24, 16:00
105.77
-0.02
(-0.02%)
After-Hours: 20:00
Celcuity Research and Development Expense (Quarterly) : 34.92M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 171.32M |
| Cidara Therapeutics, Inc. | 35.53M |
| Cogent Biosciences, Inc. | 74.38M |
| Relay Therapeutics, Inc. | 68.26M |
| Praxis Precision Medicines, Inc. | 77.51M |